Kazanskaya; Olga

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kazanskaya; Olga.The latest application filed is for "rspondins as modulators of angiogenesis and vasculogenesis".

Company Profile

4.11.14

Kazanskaya; Olga - Buchen DE
KAZANSKAYA; Olga - Heidelberg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Rspondins as modulators of angiogenesis and vasculogenesis Grant 10,538,563 - Niehrs , et al. Ja	2020-01-21
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20190359664 - Niehrs; Christof ; et al.	2019-11-28
Compositions For Diagnosis And Therapy Of Diseases Associated With Aberrant Expression Of Futrins (r-spondins) And/or Wnt App 20190194306 - NIEHRS; Christof ; et al.	2019-06-27
Rspondins as modulators of angiogenesis and vasculogenesis Grant 10,273,276 - Niehrs , et al.	2019-04-30
Compositions For diagnosis and Therapy of diseases associated with aberrant expression of Futrins (R-Spondins) and/or Wnt App 20160376349 - Niehrs; Christof ; et al.	2016-12-29
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20160009773 - Niehrs; Christof ; et al.	2016-01-14
Antagonist anti-Rspondin3 antibodies Grant 9,226,963 - Niehrs , et al. January 5, 2	2016-01-05
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt Grant 9,081,011 - Niehrs , et al. July 14, 2	2015-07-14
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt Grant 8,951,745 - Niehrs , et al. February 10, 2	2015-02-10
Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis Grant 8,926,970 - Niehrs , et al. January 6, 2	2015-01-06
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt Grant 8,921,056 - Niehrs , et al. December 30, 2	2014-12-30
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140357510 - Niehrs; Christof ; et al.	2014-12-04
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20140350226 - Niehrs; Christof ; et al.	2014-11-27
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140227713 - Niehrs; Christof ; et al.	2014-08-14
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140186917 - Niehrs; Christof ; et al.	2014-07-03
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140134703 - Niehrs; Christof ; et al.	2014-05-15
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20140056894 - Niehrs; Christof ; et al.	2014-02-27
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20130337533 - Niehrs; Christof ; et al.	2013-12-19
Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis Grant 8,580,736 - Niehrs , et al. November 12, 2	2013-11-12
Rspondins As Modulators Of Angiogenesis And Vasculogenesis App 20120088727 - Niehrs; Christof ; et al.	2012-04-12
Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists Grant 8,088,374 - Niehrs , et al. January 3, 2	2012-01-03
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt App 20070244061 - Niehrs; Christof ; et al.	2007-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.